Resources from the same session
Novel pre-clinical models to design drug combinations
Presenter: Jens Hoffmann
Session: Opportunities in clinic trial design in the era of genomics and immuno-oncology
Role of artificial intelligence in drug development
Presenter: Mark Kris
Session: Opportunities in clinic trial design in the era of genomics and immuno-oncology
Resources:
Slides
Webcast